438 results on '"Term (time)"'
Search Results
2. PIN120 The IMPACT of LONG-TERM Exposure to PM2.5, PM10 and NO2 Air Pollutants on the Age-Adjusted Mortality RATE of COVID-19 Based on the Example of Poland
3. PMS10 Trends in Leaves Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Back Pain in the United States
4. PSS16 Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Osteoarthritis in the United States
5. PSS17 Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States
6. PCN25 Systematic Literature Review of Treatment Patterns, Long-Term Efficacy, and Safety of Dasatinib Therapy for Patients with Chronic Myeloid Leukemia
7. PCV2 Real-World Outcomes of Antithrombotic Therapies in Patients with Coronary Artery Disease That Require Long-Term Oral Anticoagulation
8. PCN11 The potential long-term comparative effectiveness of larotrectinib vs. lenvatinib or sorafenib for treatment of NTRK fusion-positive metastatic thyroid cancer
9. PSY26 Healthcare Costs, Resource Utilization, and Adverse Events Associated with Long-term Oral Corticosteroid Use in Patients with Systemic Lupus Erythematosus in the United States
10. PND9 Exploring Serious Adverse Events Associated With Hospitalizations in a Long-term, Phase 3, Open-Label, Repeat-Dose, Safety Study of Diazepam Nasal Spray for Patients With Epilepsy
11. PDB34 The PRIME Type 2 Diabetes MODEL: A New, Product-Independent MODEL to Evaluate LONG-TERM Clinical and Cost Outcomes in Type 2 Diabetes
12. PIT7 Pharmacoeconomic Benefits of over-the-Counter Topical Diclofenac in the Treatment of Mild-to-Moderate ACUTE PAIN or Injury and Short-TERM PAIN Associated with Chronic Conditions in Germany
13. PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System
14. PDB28 MODEL-Based LONG-TERM Cost-Effectiveness of Once-Weekly Semaglutide Compared with Other GLP-1 Receptor Agonists in Type 2 Diabetes: A Systematic Literature Review
15. PRS9 LONG-TERM IMPACT of PRIOR Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilisation (HCRU) and Related Costs: An Observational Study (SHERLOCK)
16. PCN348 Long-Term Healthcare Resource Utilization and Costs Associated with Patients Treated with Nivolumab for Advanced Non-Small Cell Lung Cancer
17. IN2 A Model-Based Estimation of the Cost-of-Illness Associated with Neisseria gonorrhoea in England and the USA: Assessing the Potential Impact of Antimicrobial Resistance and Long-Term Health Problems
18. PBI29 Does Short-Term Gain Lead to Longer Term Pain ? the Case for Developing a Sustainable Biosimilar Marketplace
19. PDB32 A LONG-TERM Cost-Effectiveness Analysis of Treatments for Type 2 Diabetes in Portugal: Once-Weekly Semaglutide 1 MG Versus Once-Daily Empagliflozin 25 MG
20. PDB36 LONG-TERM Cost-Effectiveness Analyses of Once-Weekly Semaglutide 1 MG Versus Empagliflozin 25 MG for Treatment of Type 2 Diabetes in Three Countries: Bosnia and Herzegovina, Greece, and Slovenia
21. PND27 Modelling LONG-TERM Health Benefits of Siponimod in ACTIVE Secondary Progressive Multiple Sclerosis in Portugal
22. PDG18 LONG-TERM Cost-Effectiveness of the Sofosbuvir-Based Directing-Acting Antivirals in Treating Patients with Chronic Hepatitis C (CHC) in China: From a Healthcare Payer’S Perspective
23. PRO11 Estimating the LONG-TERM Effects of Therapy for Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) Using Individual Participant DATA
24. PMS32 LONG–TERM PAIN Management Pathways of Patients with Osteoarthritis of the HIP/Knee before Joint Replacement — a Retrospective Cohort Study Based on German Health Claims DATA
25. PMS5 EARLY CARE DECISIONS AND THE RISK OF LONG-TERM OPIOID USE IN PATIENTS WITH LOW BACK PAIN
26. PMH11 LONG-TERM MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER IN THE UNITED STATES: A COST-UTILITY ANALYSIS
27. PBI34 IMPACTS OF LONG-TERM UNCERTAINTY AND FAMILY SPILLOVER EFFECTS ON THE COST-UTILITY OF APPROVED TREATMENTS FOR SMA TYPE I
28. PCV27 COST-EFFECTIVENESS OF INSERTABLE CARDIAC MONITORS VERSUS STANDARD OF CARE OR SHORT-TO-LONG-TERM ECG MONITORING TO IDENTIFY ATRIAL FIBRILLATION AFTER CRYPTOGENIC STROKE
29. PCV22 LONG-TERM BENEFITS OF EXPANDED ACCESS TO VALVE REPLACEMENT FOR AORTIC STENOSIS PATIENTS
30. CE1 METHODOLOGICAL CHALLENGES WITH CONDUCTING NETWORK META-ANALYSES ASSESSING LONG-TERM COMPARATIVE EFFICACY IN PSORIASIS: A CRITIQUE OF ASSUMPTIONS UNDERPINNING RECENT INDIRECT TREATMENT COMPARISONS
31. PDB6 LONG-TERM ASSOCIATION OF OBSERVED VERSUS PREDICTED MICRO- AND MACROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES MELLITUS: EXTERNAL VALIDATION OF THE CORNERSTONE DIABETES SIMULATION MODEL (CDSM)
32. PGI58 A STUDY OF LONG TERM HOSPITALIZATION COSTS IN PATIENTS WITH ULCERATIVE COLITIS USING GERMAN CLAIMS DATA
33. PDB51 PREVENTION AS A PUBLIC HEALTH MEASURE: LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF A POPULATION-BASED IODINE DEFICIENCY DISEASES PREVENTION PROGRAM
34. PND15 LONG-TERM COST-EFFECTIVENESS OF LASMIDITAN, UBROGEPANT AND RIMEGEPANT FOR TREATMENT OF ACUTE MIGRAINE
35. PDG12 THE LONG-TERM COST-EFFECTIVENESS OF VILDAGLIPTIN+ METFORMIN THERAPY RELATIVE TO COMPARATOR SULFONYLUREA+ METFORMIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
36. PCN4 ACCURACY OF LIFE YEAR GAIN PREDICTIONS FOR NIVOLUMAB MONOTHERAPY IN THE LONG TERM: AN ANALYSIS ACROSS FOUR INDICATIONS
37. PBI33 HOW NOVEL IS ICER METHODS GUIDANCE ON HIGH-IMPACT, SINGLE, AND SHORT-TERM THERAPIES?
38. PIH35 LONG-TERM PRESCRIPTION OPIOID USE AMONG OLDER ADULTS IN THE UNITED STATES
39. PCN121 LONG-TERM COST-EFFECTIVENESS MODELING COMPARING MATURITY OF DATA CUTS: A COMPARISON BETWEEN COST-EFFECTIVENESS OF NIVOLUMAB VS EVEROLIMUS IN SECOND LINE RENAL CELL CARCINOMA USING 2- OR 3-YEAR FOLLOW UP CHECKMATE-025 DATA
40. PPM8 PREDICTION MODELS OF PATIENTS WITH TYPE 2 DIABETES UNDER LONG-TERM HYPOGLYCEMIC TREATMENT BASED ON MACHINE LEARNING TECHNIQUES
41. PCN293 HOW SUCCESSFUL ARE STANDARD AND FLEXIBLE EXTRAPOLATION METHODS FOR THE LONG-TERM PROJECTION OF OVERALL SURVIVAL COMPARED TO TRIAL DATA SUBSEQUENTLY MADE AVAILABLE FOR CANCER IMMUNOTHERAPIES?
42. PRS23 THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN TO THE HEALTHCARE SYSTEM AND FAMILIES OF PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS IN INDONESIA
43. PRO128 AN EVIDENCE-BASED APPROACH TO PREDICT LONG-TERM PATIENT OUTCOMES IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME
44. PIN48 THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA
45. PRO50 THE ECONOMIC BURDEN OF SHORT-TERM ADVERSE EVENTS ASSOCIATED WITH THE CHOP CHEMOTHERAPY REGIMEN IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS IN EUROPEAN COUNTRIES: A COMPREHENSIVE LITERATURE REVIEW
46. PCN57 A MULTI-STAKEHOLDER PERSPECTIVE ON THE CHALLENGES IN DEMONSTRATING THE LONG-TERM BENEFIT OF CANCER IMMUNOTHERAPY
47. PMH16 LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION
48. PMD6 COMPARING THE LONG-TERM COSTS ASSOCIATED WITH INTRAOCULAR LENS SELECTION AND ND:YAG LASER CAPSULOTOMY POST-CATARACT SURGERY: A COST-CONSEQUENCE ANALYSIS FROM A DUTCH HEALTHCARE SYSTEM PERSPECTIVE
49. PCV18 THE LONG-TERM EFFECTS OF MAINTAINING RAASI TREATMENT IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW
50. PGI3 DEPRESCRIBING OF LONG TERM UTILIZATION OF H2 RECEPTOR ANTAGONISTS AND PROTON PUMP INHIBITORS BASED ON ENDOSCOPIC ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.